Brief: Genetron Health And Impact Therapeutics Announce Partnership To Drive Development Of Synthetic Lethal Product Pipeline
27/09/2021 11:03
Sept 27 (Reuters) - Genetron Holdings Ltd GTH.O :
* GENETRON HEALTH AND IMPACT THERAPEUTICS ANNOUNCE
PARTNERSHIP TO
DRIVE DEVELOPMENT OF SYNTHETIC LETHAL PRODUCT PIPELINE
Source text for Eikon: ID:nGNX2txjHK
Further company coverage: GTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetron Holdings
See all newsBrief: Genetron Holdings Requested That Trading Of Its ADSs On Nasdaq Be Suspended As Of Close Of Trading On March 28, 2024
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
U.S. STOCKS ON THE MOVE-Scholar Rock, Target, LL Flooring
U.S. STOCKS ON THE MOVE-First Solar, Genetron, Viasat
Genetron surges on $126 mln deal to go private